Close this search box.
Subscriber Log In

In Case You Missed It: Three Things We Learned in Our CDMO Webinar


If you missed it, the recording is available here. If you’re short on time, here are three of the key points that I took away from the session. Our speakers included Amanda Micklus from the Norstella consulting team, and Vince Spurr, one of our CDMO experts. Perhaps more importantly, we were joined by Matt Hewitt […]

In Sickness and in Health: The CDMO/Pharma Relationship


There are two inflection points where a pharma or biotech company looks to a CDMO. In one instance, it’s a technology transfer to create regional or incremental capacity, helping reduce the risk of a single-source manufacturing process. While this isn’t risk-free, it’s relatively straightforward. In recent years, though, we’ve seen an increase in companies seeking […]

CDMO Focus: Three Areas to Drive Success


CDMOs (Contract Development and Manufacturing Organisations) are key players in the biopharma market, playing a vital role in translating science into medicines that change people’s lives. Almost all pharma and biotech companies rely on CDMO services to some extent, whether that’s for clinical trials or huge marketed drugs. However, CDMOs view the market through a […]